Alerta

Utah Medical Products Inc... (UTMD)

NasdaqGS: UTMD · Precio en tiempo real · USD

70.21

-0.79 (-1.11%)

Al cierre: Aug 17, 2026, 3:50 PM

-1.11% (1D)

Precio de compra	50.76
Capitalización de mercado	223.54M
Ingresos (TTM)	36.11M
Beneficio neto (TTM)	10.49M
Beta	0.36
EPS (TTM)	3.23
Ratio PER (TTM)	21.74
Adelante PE	n/a
P/B (TTM)	1.86
P/S (TTM)	6.19
Earnings Date	Oct 22, 2026

Precio de venta	90.41
Volumen	27,964
Volumen medio (20D)	20,968
Abierto	71.07
Anterior Cerrar	71.00
Rango del día	70.02 - 72.46
Rango de 52 semanas	53.66 - 75.75
analista	n/a
Precio objetivo	n/a
Dividendos	$1.24 (1.75%)
Fecha ex dividendo	17 sept 2026

Acerca de UTMD

Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. The company provides GESCO, an umbilical vessel catheter, including DIALY-NATE disposable peritoneal dialysis sets; PAL...

[Leer más]

Industria Medical Instruments & Supplies

Sector Healthcare

IPO Fecha Mar 8, 1999

Empleados 140

Bolsa de Valores NasdaqGS

Símbolo bursátil UTMD

Sitio web https://www.utahmed.com

Perfil completo de la empresa

Desempeño financiero

En 2025, los ingresos de Utah Medical Products fueron 38.52M, una disminución de -5.83% en comparación con 40.9M del año anterior. Las ganancias fueron 11.29M, una disminución de -18.65%.

Estados financieros

Sorpresa de resultados

Utah Medical Products ha publicado sus resultados trimestrales en Apr 24, 2014:

Ingresos de n/a falla las estimaciones por $0, con -100.00% Disminución interanual.

EPS de 0.72 falla las estimaciones por -0.07, con -1.37% Disminución interanual.

Próxima publicación de resultados

Está previsto que Utah Medical Products Inc. publique sus resultados el Oct 22, 2026, antes de que se abra el mercado.
Los analistas proyectan ingresos de ... Actualizar

Noticias

2 semanas hace · Zacks

Utah Medical's Q2 Earnings Down Y/Y Due to Customer Losses

UTMD's Q2 earnings per share decline 10.1% year over year, while quarterly revenues face pressure from lost customers and slower new business growth.

2 meses hace · Zacks

The Zacks Analyst Blog Highlights Berkshire, Eli Lilly, Walmart, Universal Health Realty Income and Utah

BRK.B, LLY and WMT headline top analyst reports, highlighting business strengths, growth drivers and key risks shaping their outlooks.

2 meses hace · Zacks

Top Analyst Reports for Berkshire Hathaway, Eli Lilly & Walmart

Berkshire Hathaway, Eli Lilly and Walmart headline new analyst reports, highlighting growth drivers, opportunities and key risks shaping their outlooks.

3 meses hace · Zacks

Utah Medical's Q1 Earnings Fall Y/Y Due to Elevated Litigation Costs

UTMD reports a year-over-year decline in Q1 earnings per share and sales, pressured by lost distributor business and higher costs, despite improved margins and a strong balance sheet.

4 meses hace · Zacks

Utah Medical Gains 32% in a Year: Should You Buy the Stock?

UTMD's niche leadership, global footprint, and strong cash generation position it to benefit from rising demand for high-quality maternal and neonatal healthcare solutions.

Página 1 de 2

Utah Medical Products Inc... (UTMD)